Clinical trial
A Study to Determine the Effect of Montelukast Sodium as an Episode Modifier in…
NCT00140881 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00140881 |
|---|---|
| Title | A Study to Determine the Effect of Montelukast Sodium as an Episode Modifier in the Treatment of Infrequent Episodic Asthma in Children (0476-165) |
| Official title | A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of Montelukast Sodium as an Episode Modifier in the Treatment of Infrequent Episodic Asthma in Children |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | MK0476, montelukast sodium, Comparator: placebo |
| Enrollment | 220 |
| Start date | Jun 1, 2000 |
| Primary completion | Feb 14, 2003 |
| Completion | Feb 14, 2003 |
| First posted | Sep 1, 2005 |
| Last update posted | Aug 14, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: